Management of Motor Rehabilitation in Individuals with Muscular Dystrophies. 1 Consensus Conference Report from UILDM - Italian Muscular Dystrophy Association (Rome, January 25-26, 2019)

Overview

Journal Acta Myol

Date 2021 Aug 6

PMID 34355124

Authors

Maria Elena Lombardo

Elena Carraro

Cristina Sancricca

Michela Armando

Michela Catteruccia

Elena Mazzone

Giulia Ricci

Ferdinando Salamino

Filippo Maria Santorelli

Massimiliano Filosto

Affiliations

Soon will be listed here.

Abstract

Muscular dystrophy (MD) is a group of neuromuscular diseases characterized by progressive muscle weakness due to various mutations in several genes involved in muscle structure and function. The age at onset, evolution and severity of the different forms of MD can vary and there is often impairment of motor function and activities of daily living. Although there have been important scientific advances with regard to pharmacological therapies for many forms of MD, rehabilitation management remains central to ensuring the patient's psychophysical well-being. Here we report the results of an Italian consensus conference promoted by UILDM (Unione Italiana Lotta alla Distrofia Muscolare, the Italian Muscular Dystrophy Association) in order to establish general indications and agreed protocols for motor rehabilitation of the different forms of MD.

References

Sackley C, Disler P, Turner-Stokes L, Wade D . Rehabilitation interventions for foot drop in neuromuscular disease. Cochrane Database Syst Rev. 2007; (2):CD003908. DOI: 10.1002/14651858.CD003908.pub2. View

Okkersen K, Jimenez-Moreno C, Wenninger S, Daidj F, Glennon J, Cumming S . Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial. Lancet Neurol. 2018; 17(8):671-680. DOI: 10.1016/S1474-4422(18)30203-5. View

Gianola S, Pecoraro V, Lambiase S, Gatti R, Banfi G, Moja L . Efficacy of muscle exercise in patients with muscular dystrophy: a systematic review showing a missed opportunity to improve outcomes. PLoS One. 2013; 8(6):e65414. PMC: 3680476. DOI: 10.1371/journal.pone.0065414. View

Wang C, Bonnemann C, Rutkowski A, Sejersen T, Bellini J, Battista V . Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol. 2010; 25(12):1559-81. PMC: 5207780. DOI: 10.1177/0883073810381924. View

Tawil R, Kissel J, Heatwole C, Pandya S, Gronseth G, Benatar M . Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the.... Neurology. 2015; 85(4):357-64. PMC: 4520817. DOI: 10.1212/WNL.0000000000001783. View

Bos I, Stallinga H, Middel B, Kuks J, Wynia K . Validation of the ICF core set for neuromuscular diseases. Eur J Phys Rehabil Med. 2012; 49(2):179-87. View

Voet N, van der Kooi E, van Engelen B, Geurts A . Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev. 2019; 12:CD003907. PMC: 6953420. DOI: 10.1002/14651858.CD003907.pub5. View

Iolascon G, Paoletta M, Liguori S, Curci C, Moretti A . Neuromuscular Diseases and Bone. Front Endocrinol (Lausanne). 2019; 10:794. PMC: 6886381. DOI: 10.3389/fendo.2019.00794. View

Sveen M, Andersen S, Ingelsrud L, Blichter S, Olsen N, Jonck S . Resistance training in patients with limb-girdle and becker muscular dystrophies. Muscle Nerve. 2012; 47(2):163-9. DOI: 10.1002/mus.23491. View

10.

Pane M, Mazzone E, Sivo S, Fanelli L, de Sanctis R, DAmico A . The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boys. PLoS Curr. 2015; 6. PMC: 4208936. DOI: 10.1371/currents.md.a93d9904d57dcb08936f2ea89bca6fe6. View

11.

Angelini C, Peterle E, Gaiani A, Bortolussi L, Borsato C . Dysferlinopathy course and sportive activity: clues for possible treatment. Acta Myol. 2011; 30(2):127-32. PMC: 3235880. View

12.

Ferreira M, Sherrington C, Smith K, Carswell P, Bell R, Bell M . Physical activity improves strength, balance and endurance in adults aged 40-65 years: a systematic review. J Physiother. 2012; 58(3):145-56. DOI: 10.1016/S1836-9553(12)70105-4. View

13.

Orngreen M, Olsen D, Vissing J . Aerobic training in patients with myotonic dystrophy type 1. Ann Neurol. 2005; 57(5):754-7. DOI: 10.1002/ana.20460. View

14.

Fagoaga J, Girabent-Farres M, Bagur-Calafat C, Febrer A, Steffensen B . [Functional assessment for people unable to walk due to spinal muscular atrophy and Duchenne muscular dystrophy. Translation and validation of the Egen Klassifikation 2 scale for the Spanish population]. Rev Neurol. 2015; 60(10):439-46. View

15.

Cudia P, Weis L, Baba A, Kiper P, Marcante A, Rossi S . Effects of Functional Electrical Stimulation Lower Extremity Training in Myotonic Dystrophy Type I: A Pilot Controlled Study. Am J Phys Med Rehabil. 2016; 95(11):809-817. DOI: 10.1097/PHM.0000000000000497. View

16.

Anziska Y, Inan S . Exercise in neuromuscular disease. Semin Neurol. 2014; 34(5):542-56. DOI: 10.1055/s-0034-1396008. View

17.

Gagnon C, Heatwole C, Hebert L, Hogrel J, Laberge L, Leone M . Report of the third outcome measures in myotonic dystrophy type 1 (OMMYD-3) international workshop Paris, France, June 8, 2015. J Neuromuscul Dis. 2018; 5(4):523-537. DOI: 10.3233/JND-180329. View

18.

Vissing C, Preisler N, Husu E, Prahm K, Vissing J . Aerobic training in patients with anoctamin 5 myopathy and hyperckemia. Muscle Nerve. 2014; 50(1):119-23. DOI: 10.1002/mus.24112. View

19.

Birnkrant D, Bushby K, Bann C, Apkon S, Blackwell A, Brumbaugh D . Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018; 17(3):251-267. PMC: 5869704. DOI: 10.1016/S1474-4422(18)30024-3. View

20.

Lexell J, Brogardh C . The use of ICF in the neurorehabilitation process. NeuroRehabilitation. 2014; 36(1):5-9. DOI: 10.3233/NRE-141184. View